We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOE
2376
DELISTED
Ferro Corporation
FOE
$1.65M ﹤0.01%
123,041
+54,668
+80% +$725K
ESNT icon
2377
Essent Group
ESNT
$6.12B
$1.65M ﹤0.01%
75,404
+50,381
+201% +$1.05M
HTWR
2378
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$1.65M ﹤0.01%
28,483
+2,658
+10% +$86.9K
AZN icon
2379
AstraZeneca
AZN
$266B
$1.64M ﹤0.01%
27,186
-15,613
-36% -$907K
INTC icon
2380
CALL
Intel
INTC
$460B
$1.64M ﹤0.01%
50,000
-50,000
-50% -$1.57M
ANIK icon
2381
Anika Therapeutics
ANIK
$242M
$1.64M ﹤0.01%
30,536
-15,168
-33% -$715K
DPLO
2382
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.64M ﹤0.01%
46,796
+11,507
+33% +$362K
LITE icon
2383
Lumentum
LITE
$53.9B
$1.64M ﹤0.01%
67,629
+28,128
+71% +$697K
SEMG
2384
DELISTED
SEMGROUP CORPORATION
SEMG
$1.64M ﹤0.01%
50,301
-117,452
-70% -$3.41M
SYBT icon
2385
Stock Yards Bancorp
SYBT
$2.68B
$1.64M ﹤0.01%
57,955
+14,597
+34% +$396K
FBC
2386
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.63M ﹤0.01%
66,919
-21,307
-24% -$493K
EFT
2387
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$1.63M ﹤0.01%
121,352
+29,790
+33% +$397K
EGRX
2388
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.63M ﹤0.01%
41,934
-21,531
-34% -$897K
INFN
2389
DELISTED
Infinera Corporation Common Stock
INFN
$1.63M ﹤0.01%
144,208
+42,662
+42% +$558K
NP
2390
DELISTED
Neenah, Inc. Common Stock
NP
$1.63M ﹤0.01%
22,470
-3,483
-13% -$234K
UNVR
2391
DELISTED
Univar Solutions Inc.
UNVR
$1.62M ﹤0.01%
85,485
-9,152
-10% -$166K
EVR icon
2392
Evercore
EVR
$12.1B
$1.62M ﹤0.01%
36,559
-99
-0.3% -$4.93K
IGE icon
2393
iShares North American Natural Resources ETF
IGE
$741M
$1.62M ﹤0.01%
48,640
+26,437
+119% +$845K
LILA icon
2394
Liberty Latin America Class A
LILA
$1.63B
$1.62M ﹤0.01%
78,300
+62,937
+410% +$1.49M
INVA icon
2395
Innoviva
INVA
$1.57B
$1.61M ﹤0.01%
153,185
+26,543
+21% +$314K
HW
2396
DELISTED
Headwaters Inc
HW
$1.61M ﹤0.01%
89,873
+2,157
+2% +$40.7K
MEET
2397
DELISTED
The Meet Group, Inc. Common Stock
MEET
$1.61M ﹤0.01%
301,854
+222,014
+278% +$824K
ISEE
2398
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.6M ﹤0.01%
31,432
-9,645
-23% -$479K
PCTY icon
2399
Paylocity
PCTY
$7.32B
$1.6M ﹤0.01%
37,110
+11,251
+44% +$422K
SYNT
2400
DELISTED
Syntel Inc
SYNT
$1.6M ﹤0.01%
35,410
+7,731
+28% +$349K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.